SEC Comment Letter 0000000000-26-004089 to Evommune, Inc. (EVMN) (CIK 0002044725)
Evommune, Inc. (EVMN) (CIK 0002044725)
Date: April 22, 2026 · CIK: 0002044725 · Accession: 0000000000-26-004089
AI Filing Summary & Sentiment
File numbers found in text: 333-295140
Letter
April 22, 2026 Luis Peña Chief Executive Officer Evommune, Inc. 1891 Page Mill Road Palo Alto, CA 94304 Re: Evommune, Inc. Registration Statement on Form S-1 Filed April 17, 2026 File No. 333-295140 Dear Luis Peña: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Minkyu Park, Esq.
Show Raw Text
April 22, 2026
Luis Peña
Chief Executive Officer
Evommune, Inc.
1891 Page Mill Road
Palo Alto, CA 94304
Re: Evommune, Inc.
Registration Statement on Form S-1
Filed April 17, 2026
File No. 333-295140
Dear Luis Peña:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Minkyu Park, Esq.